the world health organization (who) decided to take hydroxychloroquine with testing of drugs to combat the coronavirus, said an expert who Anna Maria Restrepo. According to her, the experts came to the conclusion that the drug provides no benefit in the quality of medical care to reduce mortality from COVID-19. It is noted that the decision to stop testing is not recommendation the use of hydroxychloroquine as a means of prevention.

Hydroxychloroquine is a medicine against malaria, in some countries, used for the treatment of patients with coronavirus. The Ministry of healthcare shall also consider hydroxychloroquine as a means to prevent COVID-19. The drug trial was previously suspended due reports of increased mortality among patients taking the drug.

“expert group Meeting just concluded. The decision was made to discontinue use of hydroxychloroquine in the framework of the tests of Solidarity,” said Anna Maria Restrepo at the briefing.

the Study “Solidarity” who is based on comparing several drugs to find the most effective drug for the treatment of COVID-19. The tests are designed to weed out the ineffective ones and add new more promising.

the US President Donald trump said earlier that he regularly takes hydroxychloroquine for prevention. June 15 the Office for quality control of food and drug administration has revoked permission for the delivery of hospital drugs hydroxychloroquine and chloroquine for the treatment of patients with coronavirus COVID-19. The Ministry noted that the previously recommended dosage regimen of drugs “is unlikely to have antiviral activity”.